SYTL3 report

Query

Invalid input gene. Please select from the suggestions.

I. Expression across cell types

Cell ontologyData table

Name	Number of supported studies	Average coverage
natural killer cell	42 studies	43% ± 16%	Explore
CD8-positive, alpha-beta T cell	32 studies	32% ± 13%	Explore
mast cell	27 studies	46% ± 17%	Explore
T cell	24 studies	31% ± 13%	Explore
CD4-positive, alpha-beta T cell	21 studies	29% ± 13%	Explore
mature NK T cell	19 studies	39% ± 11%	Explore
regulatory T cell	18 studies	27% ± 10%	Explore
CD16-negative, CD56-bright natural killer cell, human	15 studies	47% ± 18%	Explore
CD16-positive, CD56-dim natural killer cell, human	14 studies	48% ± 15%	Explore
gamma-delta T cell	14 studies	41% ± 17%	Explore
ciliated cell	12 studies	34% ± 11%	Explore
mucosal invariant T cell	12 studies	37% ± 15%	Explore
CD8-positive, alpha-beta memory T cell	10 studies	45% ± 18%	Explore
effector memory CD8-positive, alpha-beta T cell	9 studies	46% ± 16%	Explore
innate lymphoid cell	8 studies	52% ± 15%	Explore
microglial cell	8 studies	32% ± 11%	Explore
CD4-positive, alpha-beta memory T cell	7 studies	27% ± 8%	Explore
effector CD8-positive, alpha-beta T cell	5 studies	30% ± 8%	Explore
leukocyte	5 studies	41% ± 19%	Explore
naive thymus-derived CD8-positive, alpha-beta T cell	5 studies	30% ± 8%	Explore
macrophage	5 studies	27% ± 18%	Explore
epithelial cell	4 studies	24% ± 9%	Explore
dendritic cell	4 studies	21% ± 2%	Explore
naive thymus-derived CD4-positive, alpha-beta T cell	4 studies	35% ± 6%	Explore
lymphocyte	4 studies	52% ± 25%	Explore
CD4-positive helper T cell	4 studies	46% ± 18%	Explore
granulocyte	4 studies	35% ± 18%	Explore
monocyte	4 studies	21% ± 2%	Explore
effector memory CD8-positive, alpha-beta T cell, terminally differentiated	4 studies	45% ± 20%	Explore
conventional dendritic cell	3 studies	20% ± 2%	Explore
effector CD4-positive, alpha-beta T cell	3 studies	26% ± 10%	Explore
exhausted T cell	3 studies	24% ± 6%	Explore
T follicular helper cell	3 studies	29% ± 10%	Explore
group 3 innate lymphoid cell	3 studies	29% ± 10%	Explore
T-helper 17 cell	3 studies	36% ± 22%	Explore

II. Expression across tissues

sc-RNAseq dataData table

Name	Number of supported studies	Average coverage
peripheral blood	8 studies	20% ± 4%	Explore
lung	4 studies	19% ± 3%	Explore

Bulk RNAseq dataData table

Tissue	GTEx Coverage	GTEx Average TPM	GTEx Number of samples	TCGA Coverage	TCGA Average TPM	TCGA Number of samples
thymus	100%	1790.15	653 / 653	100%	27.20	602 / 605
prostate	100%	731.79	245 / 245	98%	10.28	490 / 502
lung	100%	1931.26	578 / 578	91%	14.35	1051 / 1155
breast	94%	495.03	433 / 459	94%	9.48	1051 / 1118
kidney	93%	514.82	83 / 89	91%	12.47	819 / 901
uterus	91%	367.61	155 / 170	83%	9.30	382 / 459
esophagus	97%	456.73	1398 / 1445	70%	4.94	129 / 183
bladder	90%	604.76	19 / 21	64%	5.45	321 / 504
stomach	98%	576.72	351 / 359	52%	2.98	149 / 286
intestine	97%	596.61	933 / 966	51%	3.08	269 / 527
skin	83%	306.15	1503 / 1809	57%	4.68	271 / 472
ovary	68%	196.94	122 / 180	70%	4.62	300 / 430
lymph node	0%	0	0 / 0	100%	18.23	29 / 29
peripheral blood	100%	4145.66	929 / 929	0%	0	0 / 0
spleen	100%	2198.61	241 / 241	0%	0	0 / 0
pancreas	9%	24.91	31 / 328	90%	8.28	160 / 178
adipose	95%	517.37	1141 / 1204	0%	0	0 / 0
muscle	93%	757.14	744 / 803	0%	0	0 / 0
tonsil	0%	0	0 / 0	91%	13.63	41 / 45
heart	90%	478.45	779 / 861	0%	0	0 / 0
brain	17%	57.05	442 / 2642	64%	4.77	452 / 705
adrenal gland	44%	101.93	113 / 258	34%	2.44	78 / 230
blood vessel	71%	251.02	945 / 1335	0%	0	0 / 0
liver	32%	99.16	72 / 226	10%	0.62	39 / 406
eye	0%	0	0 / 0	11%	0.50	9 / 80
abdomen	0%	0	0 / 0	0%	0	0 / 0
bone marrow	0%	0	0 / 0	0%	0	0 / 0
diaphragm	0%	0	0 / 0	0%	0	0 / 0
gingiva	0%	0	0 / 0	0%	0	0 / 0
nasal cavity	0%	0	0 / 0	0%	0	0 / 0
nasopharynx	0%	0	0 / 0	0%	0	0 / 0
nose	0%	0	0 / 0	0%	0	0 / 0
placenta	0%	0	0 / 0	0%	0	0 / 0
spinal column	0%	0	0 / 0	0%	0	0 / 0
ureter	0%	0	0 / 0	0%	0	0 / 1